{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:10:30Z","timestamp":1783483830663,"version":"3.55.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"vor","delay-in-days":54,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK-038765"],"award-info":[{"award-number":["DK-038765"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK-079626"],"award-info":[{"award-number":["P30-DK-079626"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["T32-HD-055163"],"award-info":[{"award-number":["T32-HD-055163"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12-HD-052023"],"award-info":[{"award-number":["K12-HD-052023"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To assess the ability of medication-assisted weight loss to prevent diabetes as a function of the baseline weighted Cardiometabolic Disease Staging (CMDS) score.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We pooled data from 3,040 overweight and obese participants in three randomized controlled trials\u2014CONQUER, EQUIP, and SEQUEL\u2014assessing efficacy and safety of phentermine\/topiramate extended release (ER) for weight loss. In these double-blind phase III trials, overweight\/obese adult patients were treated with a lifestyle intervention and randomly assigned to placebo versus once-daily oral phentermine\/topiramate ER. The weighted CMDS score was calculated using baseline quantitative clinical data including waist circumference, blood glucose, blood pressure, and blood lipids. Incident diabetes was defined based on serial measures of fasting glucose, 2-h oral glucose tolerance test glucose, and\/or HbA1c.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The absolute decrease in 1-year diabetes incidence rates in subjects treated with medication versus placebo was greatest in those with high-risk CMDS scores at baseline (10.43\u20136.29%), intermediate in those with moderate CMDS risk (4.67\u20132.37%), and small in the low-risk category (1.51\u20130.67%). The number of participants needed to treat to prevent one new case of diabetes over a 56-week period was 24, 43, and 120 in those with baseline CMDS scores of \u226560, 30\u201359, and 0\u201329, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Numbers needed to treat to prevent one case of type 2 diabetes are markedly lower in patients with high-risk scores. CMDS can be used to quantify risk of diabetes in overweight\/obese individuals and predict the effectiveness of weight-loss therapy to prevent diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc17-0088","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T00:40:27Z","timestamp":1493426427000},"page":"856-862","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":35,"title":["Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine\/Topiramate Extended Release"],"prefix":"10.2337","volume":"40","clinical-trial-number":[{"clinical-trial-number":"nct00553787","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00554216","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00796367","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Fangjian","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX"},{"name":"Center for Interdisciplinary Research in Women\u2019s Health, University of Texas Medical Branch, Galveston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0822-0860","authenticated-orcid":false,"given":"W. Timothy","family":"Garvey","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, The University of Alabama at Birmingham, Birmingham, AL"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"2022031219443710700_B1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.atherosclerosis.2014.01.032","article-title":"Obesity and risk factors for cardiovascular disease and type 2 diabetes: investigating the role of physical activity and sedentary behaviour in mid-life in the 1958 British cohort","volume":"233","author":"Power","year":"2014","journal-title":"Atherosclerosis"},{"key":"2022031219443710700_B2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"2022031219443710700_B3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"2022031219443710700_B4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"2022031219443710700_B5","unstructured":"Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese [article online], 2012. Available from http:\/\/invest.arenapharm.com\/releasedetail.cfm?ReleaseID=687182. Accessed on 1 February 2012."},{"key":"2022031219443710700_B6","unstructured":"Prescribing information for QSYMIA [Internet], 2012. Available from http:\/\/www.qsymia.com\/pdf\/prescribing-information.pdf. Accessed on 1 February 2012."},{"key":"2022031219443710700_B7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4158\/EP12160.PS","article-title":"American Association of Clinical Endocrinologists\u2019 position statement on obesity and obesity medicine","volume":"18","author":"Mechanick","year":"2012","journal-title":"Endocr Pract"},{"key":"2022031219443710700_B8","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"2022031219443710700_B9","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","article-title":"Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"key":"2022031219443710700_B10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc12-s011","article-title":"Standards of medical care in diabetes--2012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031219443710700_B11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/oby.20585","article-title":"The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity","volume":"22","author":"Guo","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"2022031219443710700_B12","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"2022031219443710700_B13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"JAMA"},{"key":"2022031219443710700_B14","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"key":"2022031219443710700_B15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archinte.167.10.1068","article-title":"Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study","volume":"167","author":"Wilson","year":"2007","journal-title":"Arch Intern Med"},{"key":"2022031219443710700_B16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2337\/diacare.28.8.2013","article-title":"Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study","volume":"28","author":"Schmidt","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031219443710700_B17","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jc.2015-2691","article-title":"Development of a weighted Cardiometabolic Disease Staging (CMDS) system for the prediction of future diabetes","volume":"100","author":"Guo","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031219443710700_B18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"2022031219443710700_B19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators","volume":"129","author":"The ARIC investigators","year":"1989","journal-title":"Am J Epidemiol"},{"key":"2022031219443710700_B20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"2022031219443710700_B21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"2022031219443710700_B22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/dc13-1518","article-title":"Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release","volume":"37","author":"Garvey","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031219443710700_B23","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2337\/dc06-0560","article-title":"Effect of weight loss with lifestyle intervention on risk of diabetes","volume":"29","author":"Hamman","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031219443710700_B24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","article-title":"Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects","volume":"367","author":"Carlsson","year":"2012","journal-title":"N Engl J Med"},{"key":"2022031219443710700_B25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-8587(14)70214-1","article-title":"Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study","volume":"2","author":"Booth","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031219443710700_B26","doi-asserted-by":"crossref","first-page":"e003619","DOI":"10.1161\/JAHA.116.003619","article-title":"Trends in cardiovascular health metrics in obese adults: National Health and Nutrition Examination Survey (NHANES), 1988-2014","volume":"5","author":"Guo","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2022031219443710700_B27","first-page":"80","article-title":"Trends in intake of energy and macronutrients--United States, 1971-2000","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022031219443710700_B28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3945\/ajcn.111.020719","article-title":"Longitudinal trends in diet and effects of sex, race, and education on dietary quality score change: the Coronary Artery Risk Development in Young Adults study","volume":"95","author":"Sijtsma","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"2022031219443710700_B29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2105\/AJPH.90.5.777","article-title":"Trends in fruit and vegetable consumption among adults in 16 US states: Behavioral Risk Factor Surveillance System, 1990-1996","volume":"90","author":"Li","year":"2000","journal-title":"Am J Public Health"},{"key":"2022031219443710700_B30","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.amepre.2009.08.005","article-title":"The Healthy Lifestyle Change Program: a pilot of a community-based health promotion intervention for adults with developmental disabilities","volume":"37","author":"Bazzano","year":"2009","journal-title":"Am J Prev Med"},{"key":"2022031219443710700_B31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0145721708330153","article-title":"Translating the Diabetes Prevention Program into practice: a review of community interventions","volume":"35","author":"Jackson","year":"2009","journal-title":"Diabetes Educ"},{"key":"2022031219443710700_B32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2012.04.026","article-title":"Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022031219443710700_B33","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/CIRCULATIONAHA.114.010676","article-title":"Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals","volume":"130","author":"Egan","year":"2014","journal-title":"Circulation"},{"key":"2022031219443710700_B34","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"2022031219443710700_B35","doi-asserted-by":"crossref","unstructured":"Garvey\u2008WT, Mechanick\u2008JI, Brett\u2008EM, et al.; Reviewers of the AACE\/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Andocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity executive summary. Endocr Pract\u20082016;22:842\u2013884","DOI":"10.4158\/EP161356.ESGL"},{"key":"2022031219443710700_B36","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4158\/EP13263.RA","article-title":"New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach","volume":"19","author":"Garvey","year":"2013","journal-title":"Endocr Pract"},{"key":"2022031219443710700_B37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4158\/EP14280.PS","article-title":"American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease","volume":"20","author":"Garvey","year":"2014","journal-title":"Endocr Pract"},{"key":"2022031219443710700_B38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"2022031219443710700_B39","doi-asserted-by":"crossref","first-page":"e22863","DOI":"10.1371\/journal.pone.0022863","article-title":"Comparison of accuracy of diabetes risk score and components of the metabolic syndrome in assessing risk of incident type 2 diabetes in Inter99 cohort","volume":"6","author":"Shafizadeh","year":"2011","journal-title":"PLoS One"},{"key":"2022031219443710700_B40","doi-asserted-by":"crossref","first-page":"E1059","DOI":"10.1503\/cmaj.110387","article-title":"Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity","volume":"183","author":"Padwal","year":"2011","journal-title":"CMAJ"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc17-0088","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/7\/856\/548505\/dc170088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/7\/856\/548505\/dc170088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:27:18Z","timestamp":1647120438000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/40\/7\/856\/30040\/Cardiometabolic-Disease-Staging-Predicts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,4,28]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc17-0088","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]}}}